2017版WHO垂体神经内分泌肿瘤分类临床指导及国际疾病分类法编码分析  

Clinical guidance and International Classification of Disease coding analysis in the 2017 WHO classification of pituitary neuroendocrine tumors

作　　者：关宏[1] 郭淑芹[1] 贾同乐 GUAN Hong;GUO Shu-qin;JIA Tong-le(Department of Neurosurgery,Baoding First Central Hospital,Baoding 071000,Hebei,China)

机构地区：[1]河北省保定市第一中心医院神经外科,071000

出　　处：《中国现代神经疾病杂志》2022年第1期54-59,共6页Chinese Journal of Contemporary Neurology and Neurosurgery

摘　　要：2017年世界卫生组织发布第四版内分泌肿瘤分类(以下简称2017版分类),对垂体肿瘤分类的理论基础进行更新。垂体转录因子的发现使垂体腺瘤的分类更细化,使既往无法明确诊断、易混淆、无法判断预后的垂体腺瘤的分类得以明确。本文按照2017版分类对每种垂体腺瘤分类、诊断和预后进行分析,并结合国际疾病分类法-10(ICD-10)和ICD-O列出相应的疾病编码和形态学编码。The fourth edition of the latest classification of endocrine tumors has published by World Health Organization(WHO)in 2017,in which the theoretical basis of classification has been updated.With the discovery of specific transcription factors,the classification of pituitary adenomas which could not be diagnosed definitively and confused easily,whose prognosis is impossible to determine,has been defined.In this paper,the classification,diagnosis and prognosis of each pituitary adenoma were discussed according to the latest classification,and the corresponding disease codes were summarized based on International Classification of Disease-10(ICD-10)and ICD-O.

关 键 词：垂体肿瘤 世界卫生组织 国际疾病分类法 综述 

分 类 号：R736.4[医药卫生—肿瘤]